Human Skin Equivalents Expressing Exogenous Polypeptides

Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.


Claims

Information currently unavailable.

CPC Classifications

Download Citation


Sign in to the Lens

Feedback